| 1 | Hemangioma | 46.7% |
| 2 | hemangiopericytoma | 46.7% |
| 3 | Angiofibroma | 46.7% |
| 4 | Hemangiosarcoma | 40.7% |
| 5 | Hemangioendothelioma | 34.4% |
| 6 | leukemia | 31% |
| 7 | Neoplasms, Germ Cell and Embryonal | 31% |
| 8 | Neoplasms, Glandular and Epithelial | 31% |
| 9 | Germ Cell Cancer | 31% |
| 10 | Hemangioblastoma | 28.5% |
| 11 | Meningioma | 27.9% |
| 12 | Neuroectodermal Tumors | 26.7% |
| 13 | Neoplasms, Neuroepithelial | 24.6% |
| 14 | Gliomatosis cerebri | 24.6% |
| 15 | Carcinosarcoma | 23.1% |
| 16 | lymphangiosarcoma | 23.1% |
| 17 | melanoma | 22% |
| 18 | Histiocytic Disorders, Malignant | 20.5% |
| 19 | Adenoma | 20% |
| 20 | Ameloblastoma | 20% |
| 21 | Carcinoma | 20% |
| 22 | Chordoma | 20% |
| 23 | Lymphangioma | 20% |
| 24 | Mesenchymoma | 20% |
| 25 | Nevus | 20% |
| 26 | Teratoma | 20% |
| 27 | Hepatoblastoma | 20% |
| 28 | Mixed Tumor, Mullerian | 20% |
| 29 | Germinoma | 20% |
| 30 | Teratocarcinoma | 20% |
| 31 | Sarcoma | 20% |
| 32 | Epithelioma | 20% |
| 33 | Basal cell carcinoma | 19.6% |
| 34 | Carcinoma, Papillary | 19.6% |
| 35 | Squamous cell carcinoma | 19.6% |
| 36 | Chondrosarcoma | 19.6% |
| 37 | Craniopharyngioma | 19.6% |
| 38 | Cystadenoma | 19.6% |
| 39 | leiomyosarcoma | 19.6% |
| 40 | liposarcoma | 19.6% |
| 41 | Mesothelioma | 19.6% |
| 42 | synovial sarcoma | 19.6% |
| 43 | Neuroectodermal Tumor, Melanotic | 19.6% |
| 44 | Angiomyolipoma | 19.6% |
| 45 | Clear Cell Sarcoma of Soft Tissue | 19.6% |
| 46 | Alveolar Soft Part Sarcoma | 19.6% |
| 47 | Neuroendocrine Tumors | 19.6% |
| 48 | Sarcoma, Myeloid | 19.6% |
| 49 | Carcinoma, Basal Cell | 19.6% |
| 50 | Adenoma, Acidophil | 19.4% |
| 51 | Ganglioneuroma | 19.4% |
| 52 | Glioma | 19.4% |
| 53 | Malignant Glioma | 19.4% |
| 54 | Medulloblastoma | 19.1% |
| 55 | Carcinoma 256, Walker | 18.7% |
| 56 | Hamartoma | 18.5% |
| 57 | Neoplasms, Hormone-Dependent | 18.5% |
| 58 | Neoplasms, Multiple Primary | 18.5% |
| 59 | Paraneoplastic Syndromes | 18.5% |
| 60 | Precancerous Conditions | 18.5% |
| 61 | Neoplasms, Second Primary | 18.5% |
| 62 | Carcinoid Tumor | 18.1% |
| 63 | Neurilemmoma | 18.1% |
| 64 | Hutchinson's Melanotic Freckle | 18.1% |
| 65 | Melanoma, Amelanotic | 18.1% |
| 66 | Cystadenocarcinoma | 17.8% |
| 67 | Fibrosarcoma | 17.8% |
| 68 | Osteosarcoma | 17.8% |
| 69 | Mucoepidermoid Carcinoma | 17.8% |
| 70 | Sturge-Weber Syndrome | 17.6% |
| 71 | Hemangioma, Cavernous | 17.2% |
| 72 | Leukemia, Plasma Cell | 17.2% |
| 73 | Adenofibroma | 17% |
| 74 | Fibroadenoma | 17% |
| 75 | Malignant Fibrous Histiocytoma | 17% |
| 76 | Carcinoma, Ehrlich Tumor | 16.9% |
| 77 | Dermoid Cyst | 16.9% |
| 78 | Carcinoma, Lewis Lung | 16.9% |
| 79 | Astrocytoma | 16.8% |
| 80 | Ependymoma | 16.8% |
| 81 | oligodendroglioma | 16.8% |
| 82 | Ganglioglioma | 16.8% |
| 83 | gliosarcoma | 16.8% |
| 84 | Anaplastic astrocytoma | 16.8% |
| 85 | Anaplastic Oligodendroglioma | 16.8% |
| 86 | Malignant Carcinoid Syndrome | 16.2% |
| 87 | Bowen's Disease | 16.1% |
| 88 | Paraganglioma | 16.1% |
| 89 | Rhabdomyosarcoma | 16.1% |
| 90 | Giant Cell Tumor of Bone | 16.1% |
| 91 | Composite Lymphoma | 15.8% |
| 92 | Glioblastoma | 15.5% |
| 93 | Neuroblastoma | 15.5% |
| 94 | Glioblastoma Multiforme | 15.5% |
| 95 | Melanoma, Experimental | 15.5% |
| 96 | Dermatofibrosarcoma | 15.3% |
| 97 | Dermatofibrosarcoma Protuberans | 15.3% |
| 98 | Lymphoma | 15.3% |
| 99 | Trophoblastic Neoplasms | 15.3% |
| 100 | Leukemia, Experimental | 15.1% |
| 101 | Ganglioneuroblastoma | 14.9% |
| 102 | Adenocarcinoma | 14.8% |
| 103 | Carcinoma in Situ | 14.8% |
| 104 | Carcinoma, Transitional Cell | 14.8% |
| 105 | Phyllodes Tumor | 14.8% |
| 106 | Dysgerminoma | 14.8% |
| 107 | Lipoma | 14.8% |
| 108 | Myoma | 14.8% |
| 109 | Myxoma | 14.8% |
| 110 | Neuroma | 14.8% |
| 111 | Papilloma | 14.8% |
| 112 | Pseudomyxoma Peritonei | 14.8% |
| 113 | Seminoma | 14.8% |
| 114 | Papillomatosis | 14.8% |
| 115 | Angiolipoma | 14.8% |
| 116 | Myelolipoma | 14.8% |
| 117 | Neoplasms, Bone Tissue | 14.8% |
| 118 | Neoplasms, Fibrous Tissue | 14.8% |
| 119 | Smooth Muscle Tumor | 14.8% |
| 120 | Adenomatosis, Pulmonary | 14.8% |
| 121 | Adenomatous Polyps | 14.8% |
| 122 | Carcinoma, Large Cell | 14.8% |
| 123 | Carcinoma, Small Cell | 14.8% |
| 124 | Desmoplastic Small Round Cell Tumor | 14.8% |
| 125 | Chondroma | 14.8% |
| 126 | Enchondroma | 14.8% |
| 127 | Pheochromocytoma | 14.4% |
| 128 | Alveolar rhabdomyosarcoma | 14.4% |
| 129 | Leukemia L1210 | 14.3% |
| 130 | Leukemia P388 | 14.3% |
| 131 | Acanthoma | 14.3% |
| 132 | Choriocarcinoma | 13.4% |
| 133 | Carcinoma, Lobular | 13.4% |
| 134 | Plasmacytoma | 13.3% |
| 135 | Malignant histiocytosis | 13.2% |
| 136 | Histiocytic sarcoma | 13.2% |
| 137 | Sarcoma 180 | 12.6% |
| 138 | Endometrial Stromal Sarcoma | 12.6% |
| 139 | Sarcoma, Experimental | 12.5% |
| 140 | Carcinoid Heart Disease | 12.4% |
| 141 | Thymoma | 12.4% |
| 142 | Leukemia, Radiation-Induced | 12.2% |
| 143 | Adenoid Cystic Carcinoma | 12.2% |
| 144 | Cyst | 12.2% |
| 145 | fibroma | 12.2% |
| 146 | Fibromatosis | 12.2% |
| 147 | Neoplastic Processes | 12.2% |
| 148 | Neoplastic Syndromes, Hereditary | 12.2% |
| 149 | Osteoblastoma | 12.2% |
| 150 | Osteoma | 12.2% |
| 151 | Pregnancy Complications, Neoplastic | 12.2% |
| 152 | Rhabdomyoma | 12.2% |
| 153 | Chondromatosis | 12.2% |
| 154 | Adenocarcinoma, Clear Cell | 12.2% |
| 155 | Cholangiocarcinoma | 12.2% |
| 156 | Cervical Intraepithelial Neoplasia | 12.2% |
| 157 | Lymphoma, Extranodal NK-T-Cell | 12.2% |
| 158 | Neoplasms, Experimental | 11.9% |
| 159 | Lymphangioleiomyomatosis | 11.7% |
| 160 | Neurofibrosarcoma | 11.6% |
| 161 | Retinoblastoma | 11.1% |
| 162 | Fibromatosis, Aggressive | 10.9% |
| 163 | Fibromatosis, Abdominal | 10.9% |
| 164 | Klatskin Tumor | 10.9% |
| 165 | Abdominal Neoplasms | 10.3% |
| 166 | Erythroplasia | 10.3% |
| 167 | Follicular cyst | 10.3% |
| 168 | Head and Neck Neoplasms | 10.3% |
| 169 | Mucocele | 10.3% |
| 170 | Pilonidal Cyst | 10.3% |
| 171 | Soft Tissue Neoplasms | 10.3% |
| 172 | Thoracic Neoplasms | 10.3% |
| 173 | Thyroglossal Cyst | 10.3% |
| 174 | Synovial Cyst | 10.3% |
| 175 | Aberrant Crypt Foci | 10.3% |
| 176 | Hodgkin Disease | 9.8% |
| 177 | Lymphoma, Non-Hodgkin | 9.8% |
| 178 | Leukemia, Myelomonocytic, Chronic | 9.8% |
| 179 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 9.8% |
| 180 | Multiple Endocrine Neoplasia | 9.2% |
| 181 | Neoplasms, Radiation-Induced | 8.8% |
| 182 | Lymphomatoid Granulomatosis | 8.8% |
| 183 | Paraneoplastic Encephalomyelitis | 8.6% |
| 184 | Hydatidiform Mole | 8.5% |
| 185 | Mammary Neoplasms, Experimental | 8.4% |
| 186 | Acoustic Neuroma | 8.4% |
| 187 | Carcinoma, Pancreatic Ductal | 8.3% |
| 188 | Mastocytoma | 8.2% |
| 189 | Mastocytosis, Systemic | 8.1% |
| 190 | Leukemia, Myeloid, Chronic-Phase | 8.1% |
| 191 | Primary amyloidosis | 7.9% |
| 192 | Hepatocellular Adenoma | 7.9% |
| 193 | Basal Cell Nevus Syndrome | 7.7% |
| 194 | Mastocytosis | 7.6% |
| 195 | Optic Nerve Glioma | 7.5% |
| 196 | Nephroblastoma | 7.5% |
| 197 | Gastrointestinal Stromal Tumors | 7.4% |
| 198 | Vipoma | 7.4% |
| 199 | Digestive System Neoplasms | 7.3% |
| 200 | Endocrine Gland Neoplasms | 7.3% |
| 201 | Eye Neoplasms | 7.3% |
| 202 | Leukemia, T-Cell | 7.3% |
| 203 | Nervous System Neoplasms | 7.3% |
| 204 | Leukemia, B-Cell | 7.3% |
| 205 | neurofibroma | 7.3% |
| 206 | Lymphoma, Follicular | 7.3% |
| 207 | T-Cell Lymphoma | 7.3% |
| 208 | Mantle cell lymphoma | 7.3% |
| 209 | Bone neoplasms | 7% |
| 210 | Leukoplakia | 7% |
| 211 | Lymphocele | 7% |
| 212 | Pancreatic Cyst | 7% |
| 213 | Skin Neoplasms | 7% |
| 214 | Hematologic Neoplasms | 7% |
| 215 | Barrett Esophagus | 6.8% |
| 216 | Breast Cyst | 6.8% |
| 217 | Actinic keratosis | 6.8% |
| 218 | Mediastinal Cyst | 6.8% |
| 219 | Neoplasm Invasiveness | 6.8% |
| 220 | Neoplasm Metastasis | 6.8% |
| 221 | Neoplasm Recurrence, Local | 6.8% |
| 222 | Parovarian Cyst | 6.8% |
| 223 | Pericardial Cyst | 6.8% |
| 224 | Splenic Neoplasms | 6.8% |
| 225 | Thymic Cyst | 6.8% |
| 226 | Carcinogenesis | 6.8% |
| 227 | Myxoid cyst | 6.8% |
| 228 | Metastasis | 6.8% |
| 229 | Mesoblastic Nephroma | 6.7% |
| 230 | Retroperitoneal Neoplasms | 6.7% |
| 231 | Prolactinoma | 6.5% |
| 232 | Growth Hormone-Secreting Pituitary Adenoma | 6.5% |
| 233 | Tuberous Sclerosis | 6.1% |
| 234 | Multiple Endocrine Neoplasia Type 1 | 6% |
| 235 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 6% |
| 236 | Leukemia, Large Granular Lymphocytic | 6% |
| 237 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6% |
| 238 | Lymphoma, T-Cell, Cutaneous | 6% |
| 239 | Lymphoma, AIDS-Related | 6% |
| 240 | Enteropathy-Associated T-Cell Lymphoma | 6% |
| 241 | Primary Effusion Lymphoma | 6% |
| 242 | insulinoma | 5.7% |
| 243 | Waldenstrom Macroglobulinemia | 5.7% |
| 244 | Multiple Myeloma | 5.7% |
| 245 | Dupuytren Contracture | 5.6% |
| 246 | granulosa cell tumor | 5.5% |
| 247 | Carcinoma, Ovarian Epithelial | 5.5% |
| 248 | Urticaria Pigmentosa | 5.5% |
| 249 | Parathyroid Neoplasms | 5.5% |
| 250 | Peritoneal Neoplasms | 5.5% |
| 251 | Thyroid Neoplasm | 5.5% |
| 252 | Thyroid carcinoma | 5.5% |
| 253 | Gastrinoma | 5.4% |
| 254 | Glucagonoma | 5.4% |
| 255 | Mycosis Fungoides | 5.4% |
| 256 | Lymphomatoid Papulosis | 5.4% |
| 257 | Plasmablastic lymphoma | 5.4% |
| 258 | Adrenocortical carcinoma | 5.4% |
| 259 | Adenomatous Polyposis Coli | 5.1% |
| 260 | Corpus Luteum Cyst | 5% |
| 261 | Ovarian Cysts | 5% |
| 262 | Liver Neoplasms, Experimental | 5% |
| 263 | Leydig Cell Tumor | 4.9% |
| 264 | Tracheal Neoplasms | 4.8% |
| 265 | Leukoplakia, Oral | 4.6% |
| 266 | Paraneoplastic Cerebellar Degeneration | 4.6% |
| 267 | Pancreatic Neoplasm | 4.6% |
| 268 | Renal Cell Carcinoma | 4.6% |
| 269 | Papillary Renal Cell Carcinoma | 4.6% |
| 270 | Mouth Neoplasms | 4.5% |
| 271 | Central Nervous System Neoplasms | 4.5% |
| 272 | Vascular Neoplasms | 4.5% |
| 273 | Thymus Neoplasms | 4.5% |
| 274 | Nasopharyngeal carcinoma | 4.5% |
| 275 | Carcinoma, Endometrioid | 4.4% |
| 276 | Genital Neoplasms, Female | 4.4% |
| 277 | Pancreatic Pseudocyst | 4.4% |
| 278 | Lymphatic Metastasis | 4.4% |
| 279 | Neoplasms, Unknown Primary | 4.4% |
| 280 | Leukemic Infiltration | 4.4% |
| 281 | Breast Neoplasms, Male | 4.4% |
| 282 | Neoplasm Micrometastasis | 4.4% |
| 283 | Triple Negative Breast Neoplasms | 4.4% |
| 284 | Choledochal Cyst | 4.1% |
| 285 | Burkitt Lymphoma | 4% |
| 286 | Peutz-Jeghers Syndrome | 4% |
| 287 | Thyroid Nodule | 3.9% |
| 288 | Esophageal Neoplasms | 3.9% |
| 289 | Limbic Encephalitis | 3.8% |
| 290 | Denys-Drash Syndrome | 3.8% |
| 291 | Sezary Syndrome | 3.6% |
| 292 | Adrenal Gland Neoplasms | 3.4% |
| 293 | Gastrointestinal Neoplasms | 3.4% |
| 294 | Genital Neoplasms, Male | 3.4% |
| 295 | Liver neoplasms | 3.4% |
| 296 | Uveal Neoplasms | 3.4% |
| 297 | Urologic Neoplasms | 3.4% |
| 298 | Lambert-Eaton Myasthenic Syndrome | 3.3% |
| 299 | Testicular Neoplasms | 3.3% |
| 300 | Sebaceous Gland Neoplasms | 3.3% |
| 301 | Spinal Neoplasms | 3.3% |
| 302 | Bone Marrow Neoplasms | 3.3% |
| 303 | Meningeal Neoplasms | 3.3% |
| 304 | Polycystic Ovary Syndrome | 3.3% |
| 305 | Opsoclonus-Myoclonus Syndrome | 2.9% |
| 306 | Meningeal Carcinomatosis | 2.7% |
| 307 | Palatal Neoplasms | 2.6% |
| 308 | Ear Neoplasms | 2.6% |
| 309 | Eyelid Neoplasms | 2.6% |
| 310 | Lung Neoplasms | 2.6% |
| 311 | Pleural Neoplasms | 2.6% |
| 312 | Myelitis, Transverse | 2.6% |
| 313 | Nose Neoplasms | 2.6% |
| 314 | Cell Transformation, Viral | 2.5% |
| 315 | Brain Neoplasms | 2.5% |
| 316 | Salivary Gland Neoplasms | 2.5% |
| 317 | Spinal Cord Neoplasms | 2.5% |
| 318 | Tongue Neoplasms | 2.5% |
| 319 | Uterine Neoplasms | 2.4% |
| 320 | Vaginal Neoplasms | 2.4% |
| 321 | Vulvar Neoplasms | 2.4% |
| 322 | Uterine Cancer | 2.4% |
| 323 | Fallopian Tube Neoplasms | 2.4% |
| 324 | Xeroderma Pigmentosum | 2.2% |
| 325 | Pituitary Adenoma | 2.2% |
| 326 | Pituitary Neoplasms | 2.2% |
| 327 | ovarian neoplasm | 2.2% |
| 328 | Bronchial Neoplasms | 2.1% |
| 329 | Pharyngeal Neoplasms | 2.1% |
| 330 | Multiple Pulmonary Nodules | 2.1% |
| 331 | Supratentorial Neoplasms | 2% |
| 332 | Central Nervous System Cysts | 2% |
| 333 | Endometrial Neoplasms | 2% |
| 334 | Bile Duct Neoplasms | 2% |
| 335 | gallbladder neoplasm | 2% |
| 336 | Intestinal Neoplasms | 2% |
| 337 | Penile Neoplasms | 2% |
| 338 | Prostatic Neoplasms | 2% |
| 339 | Stomach Neoplasms | 2% |
| 340 | Polycythemia Vera | 1.9% |
| 341 | Brain Stem Neoplasms | 1.8% |
| 342 | Laryngeal neoplasm | 1.7% |
| 343 | Choroid Plexus Papilloma | 1.7% |
| 344 | Hypopharyngeal Neoplasms | 1.7% |
| 345 | Pleural Effusion, Malignant | 1.7% |
| 346 | Hypopharyngeal Cancer | 1.7% |
| 347 | Zollinger-Ellison syndrome | 1.6% |
| 348 | Bladder Neoplasm | 1.6% |
| 349 | Kidney Neoplasm | 1.6% |
| 350 | Ureteral Neoplasms | 1.6% |
| 351 | Urethral Neoplasms | 1.6% |
| 352 | Parotid Neoplasms | 1.6% |
| 353 | Prostatic Neoplasms, Castration-Resistant | 1.6% |
| 354 | Nelson Syndrome | 1.6% |
| 355 | Tonsillar Neoplasms | 1.5% |
| 356 | Cerebellar Neoplasms | 1.4% |
| 357 | Cecal Neoplasms | 1.3% |
| 358 | Duodenal Neoplasms | 1.3% |
| 359 | Radicular Cyst | 1.2% |
| 360 | Appendiceal Neoplasms | 1.2% |
| 361 | Colonic Neoplasms | 1.2% |
| 362 | Rectal Neoplasms | 1.2% |
| 363 | Nasopharyngeal Neoplasms | 1.2% |
| 364 | Colorectal Neoplasms | 1.2% |
| 365 | Paranasal Sinus Neoplasms | 1% |
| 366 | Anus Neoplasms | 1% |
| 367 | Sigmoid Neoplasms | 1% |
| 368 | Maxillary Sinus Neoplasms | 0.9% |